BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14515672)

  • 1. [Pharmacologic clinical monitoring of serum vancomycin levels in pediatric patients].
    Nandí-Lozano E; Ramírez-López E; Avila-Figueroa C
    Rev Invest Clin; 2003; 55(3):276-80. PubMed ID: 14515672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin dosage requirements among pediatric intensive care unit patients with normal renal function.
    Glover ML; Cole E; Wolfsdorf J
    J Crit Care; 2000 Mar; 15(1):1-4. PubMed ID: 10757191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
    Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia.
    Zimmermann AE; Katona BG; Plaisance KI
    Pharmacotherapy; 1995; 15(1):85-91. PubMed ID: 7739950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monitoring of vancomycin in pediatrics].
    Delicourt A; Touzin K; Lavoie A; Therrien R; Lebel D
    Med Mal Infect; 2012 Apr; 42(4):167-70. PubMed ID: 22424794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of serum vancomycin concentrations in pediatric patients with normal renal function.
    Khotaei GT; Jam S; SeyedAlinaghi S; Motamed F; Nejat F; Taghi M; Ashtiani H; Izadyar M
    Acta Med Iran; 2010; 48(2):91-4. PubMed ID: 21133000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective drug utilization evaluation of vancomycin usage in paediatric patients.
    Hing WC; Bek SJ; Lin RT; Li SC
    J Clin Pharm Ther; 2004 Aug; 29(4):359-65. PubMed ID: 15271103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and efficacy of vancomycin for staphylococcal infections in children.
    Schaad UB; Nelson JD; McCracken GH
    Rev Infect Dis; 1981; 3 suppl():S282-8. PubMed ID: 7342292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of vancomycin in anuria.
    Cunha BA; Quintiliani R; Deglin JM; Izard MW; Nightingale CH
    Rev Infect Dis; 1981; 3 suppl():S269-72. PubMed ID: 7342290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic monitoring of vancomycin in critical care pediatric patients].
    Zylbersztajn BL; Travaglianti M; Weller G; Mato HG
    Arch Argent Pediatr; 2008 Feb; 106(1):26-31. PubMed ID: 18636130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin serum levels and toxicity in chronic hemodialysis patients with Staphylococcus aureus bacteremia.
    Masur H; Francioli P; Ruddy M; Murray HW
    Clin Nephrol; 1983 Aug; 20(2):85-8. PubMed ID: 6616979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin dosing in obese pediatric patients.
    Moffett BS; Kim S; Edwards MS
    Clin Pediatr (Phila); 2011 May; 50(5):442-6. PubMed ID: 21282257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
    Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
    Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic monitoring of intravenous vancomycin in a pediatric critical care unit].
    Villena R; González CA; Nalegach ME; Vásquez A; Villareal M; Drago M
    Rev Chilena Infectol; 2014 Jun; 31(3):249-53. PubMed ID: 25146197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of vancomycin therapeutic drug monitoring trends at pediatric hospitals.
    Moffett BS; Edwards MS
    Pediatr Infect Dis J; 2013 Jan; 32(1):32-5. PubMed ID: 22926218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum vancomycin concentrations: reappraisal of their clinical value.
    Cantú TG; Yamanaka-Yuen NA; Lietman PS
    Clin Infect Dis; 1994 Apr; 18(4):533-43. PubMed ID: 8038306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
    Nahata MC
    Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.